Birmingham Vascular is categorized under Internal Medicine Doctors in Birmingham, AL and active since 2010.
Birmingham Vascular was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Robert W Heidepriem at the company’s single location by writing to 2018 Brookwood Med Center Drive # 214, Birmingham, Alabama AL 35209 or by phoning (205) 423-2495. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Birmingham Vascular |
| Contact Person: | Robert W Heidepriem |
| Address: | 2018 Brookwood Med Center Drive # 214, Birmingham, Alabama 35209 |
| Phone Number: | (205) 423-2495 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Birmingham Vascular was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Robert W Heidepriem for inquiries that concern Birmingham Vascular by calling the company number (205) 423-2495, as your correspondence is most welcome. Additionally, the physical location of the single location of Birmingham Vascular can be found at the coordinates 33.46348,-86.775924 as well as the street address 2018 Brookwood Med Center Drive # 214 in Birmingham, Alabama 35209.
For its online presence, you may visit Birmingham Vascular’s website at and engage with its social media outlets through on Twitter and on Facebook.